178813-78-0 Usage
General Description
2,6-Dichloro-3-fluorobenzoic acid is a scientific compound that incorporates elements including chlorine, fluorine, and benzoic acid. This highly specific chemical, often used in scientific and industrial applications, is characterized by its unique structure which includes dichloro (two chlorine atoms), fluoro (one fluorine atom) and benzoic acid. A key aspect of this compound is its reactivity due to the presence of the acid group. It promotes the conjugation in the benzene ring, which contributes to its potential uses in organic synthesis. It also has potential implications in the creation and development of pharmaceuticals and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 178813-78-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,8,1 and 3 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 178813-78:
(8*1)+(7*7)+(6*8)+(5*8)+(4*1)+(3*3)+(2*7)+(1*8)=180
180 % 10 = 0
So 178813-78-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H3Cl2FO2/c8-3-1-2-4(10)6(9)5(3)7(11)12/h1-2H,(H,11,12)
178813-78-0Relevant articles and documents
Synthetic method of 2,6-dichloro-3-fluorobenzonitrile
-
Paragraph 0037-0042, (2019/11/12)
The invention provides a synthetic method of 2,6-dichloro-3-fluorobenzonitrile, and belongs to the field of pesticide and medicine intermediate preparation. The problems of low yield and the like of an existing synthetic method of the 2,6-dichloro-3-fluor
Fused Bicyclic Kinase Inhibitors
-
Page/Page column 23, (2011/11/30)
Compounds of Formula I, as shown below and defined herein: pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by at least one of RON, MET or ALK. This Abstract is not limiting of the invention.
SUBSTITUTED PYRROLO[2,3-B]-PYRIDINES AND-PYRAZINES
-
Page/Page column 29-30, (2010/07/10)
Compounds of Formula I, as shown below and defined herein:(I) pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by Ron and/or Met.
